Latest Stock Buy or Sell?
Make More Informed Decisions!

Today, Darren Sissons commented about whether AUKNY-OTC, ACO.X-T, ACN-N, ZM-Q, TSM-N, WDC-Q, IBM-N, TRZ-T, COST-Q, VOD-Q, MURGF-OTC, BP-N, TSLA-Q, JPM-N, PYPL-Q, SQ-N, LSPD-T, BB-T, PFE-N, ABT-N, BA-N, AMLP-N are stocks to buy or sell.

N/A
A Comment -- General Comments From an Expert
Market. This too shall pass. March was a panic period. We are going to come off the COVID lock-down and some sectors will be heavily beaten down that have great value. There will be opportunities to let some investments go that make no since in a post-COVID environment. The key is if investors will read through the horrific results from during lock-down. When it comes to an end, we could see a quick recovery of profitability; however some companies will not have handled it. Fixed income is going to be a large challenge. Capital will be pushed into the equity markets. Companies that have high return on equity and don’t need a lot of capital will be well positioned to grow. Cyclicals will do well too.
Unknown
RISKY
Alerian MLP ETF
He is not a big fan of ETFs. MPL ETFs get around foreign tax with-holdings. You are investing in an environment of weak energy prices. If you have some riskier money you might look at this one. He would not tend to buy it for his clients. He thinks it will have some resistance here but he likes the structure.
E.T.F.'s
DON'T BUY
Boeing
The MAX being grounded has been very problematic. You can wait 12-18 months and look to see if the story has improved.
Transportation
COMMENT
Abbott Labs

ABT-N vs. PFE-N. Abbot Labs has a Great franchise. Very well loved by the investment community. You are really not getting any opportunity to invest at a cheaper valuation. PFE-N is somewhat of a drug ETF. They have a big portfolio. You are bidding on their strategy of buying and selling drug lines. This one will be well positioned. The entry price is not the greatest but you could buy it and you would be fine.

biotechnology / pharmaceutical
COMMENT
Pfizer Inc

ABT-N vs. PFE-N. Abbot Labs has a Great franchise. Very well loved by the investment community. You are really not getting any opportunity to invest at a cheaper valuation. PFE-N is somewhat of a drug ETF. They have a big portfolio. You are bidding on their strategy of buying and selling drug lines. This one will be well positioned. The entry price is not the greatest but you could buy it and you would be fine.

biotechnology / pharmaceutical
SELL ON STRENGTH
BlackBerry

He believes there are better opportunities. OTEX-T is a more interesting company. If you have made money then it is time to move on.

electrical / electronic
DON'T BUY
It is growing quite quickly right now. It does not really have any profit, so the challenge is on valuation. You are bidding on the growth, or ultimately an acquisition. One of the challenges of buying high priced stocks after a run is whether you will be the one left holding the bag at the end of the day. He thinks it is being pushed up because people want to buy Canadian.
Technology
DON'T BUY
Block Inc

SQ-N vs. PYPL-Q. The broader payment processing space is great but he prefers V-N. These are expensive stocks. PYPL-Q has abroad offering so probably the better one to buy. He would say that you should look at the best-of-breed, V-N. Paypal would be the preference between the two, however.

Technology
DON'T BUY

SQ-N vs. PYPL-Q. The broader payment processing space is great but he prefers V-N. These are expensive stocks. PYPL-Q has abroad offering so probably the better one to buy. He would say that you should look at the best-of-breed, V-N. Paypal would be the preference between the two, however.

0
COMMENT
In 2000 we saw that collateralized debt pulls were effectively held off-balance sheet. These can result in the results being quite volatile. This time they are a little more in-house, but in the end the entity that holds them could be in for some significant pain. In Canada the banks hold them and will pursue you to the fullest extend of the law.
Financial Services
PARTIAL SELL
Tesla Inc
At one point someone is going to have to pay for the extra capacity of charging eclectic cars. He would wait for 5 years. TSLA-Q is an expensive start-up run by a guy he does not have much confidence in. He would take your gains off the table.
Consumer Products
PAST TOP PICK
BP PLC
(A Top Pick Jun 11/19, Down 38%) The stock has recovered. It has proven to be so volatile. He is lightening up on his energy exposure. You may want to hold it for another year or two to get into a more normalized environment.
integrated oils
PAST TOP PICK
(A Top Pick Jun 11/19, Up 9%) They are not going to absorb covid-relalted business interruption. He likes it and it continues to be a core holding at this point.
insurance
PAST TOP PICK
Vodafone Group PLC
(A Top Pick Jun 11/19, Up 2%) The telcos outside of Canada have performed quite poorly. This is quite an attractive level. VOD0N will improve as well as dividends increasing over time. He is prepared to hold this.
Telecommunications
WEAK BUY
Sobeys had an 18% increase in earnings even after the extra cost of front line workers. A lot of people are flocking to local supermarkets. As people become more comfortable wearing masks, visits to Costco will become much more meaningful. Longer term this company is effectively a tax on consumption. He prefers other options and would prefer to see this one a little bit cheaper.
department stores